Skip to main content

News

Nancy Pelosi's drug-pricing talks with the Trump administration are about meditating fights between corporate interests

By The Intercept  
   April 22, 2019

A lobbyist for the hospital and insurance industries, as well as pharmacy benefit manager middlemen who negotiate with drug companies for discounts, is among the small handful of policy experts advising House Speaker Nancy Pelosi on her drug-pricing legislation strategy. The lobbyist, Lauren Aronson, has been working closely with top Pelosi policy aide Wendell Primus and in consultation with the Trump administration to find a drug-pricing compromise solution.

Full story


Get the latest on healthcare leadership in your inbox.